158 related articles for article (PubMed ID: 20845532)
1. Management of hepatocellular carcinoma: from prevention to molecular targeted therapy. Proceedings of the 3rd International Kobe Liver Symposium on HCC with an International Liver Cancer Association (ILCA) Scientific Session. Hyogo, Japan, June 6-7, 2009.
Oncology; 2010 Jul; 78 Suppl 1():1-190. PubMed ID: 20845532
[No Abstract] [Full Text] [Related]
2. Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress.
Kudo M
Oncology; 2010 Jul; 78 Suppl 1():180-8. PubMed ID: 20616602
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline.
Izumi N
Oncology; 2010 Jul; 78 Suppl 1():78-86. PubMed ID: 20616588
[TBL] [Abstract][Full Text] [Related]
4. Proceedings of the International Symposium of Multi-Disciplinary Therapy for Hepatocellular Carcinoma. March 22, 1997.
Hepatogastroenterology; 1998; 45(24):1936-2470. PubMed ID: 10348633
[No Abstract] [Full Text] [Related]
5. Hepatocellular Carcinoma: Eastern and Western Experiences. Proceedings of an international congress. Tokyo, Japan, December 9, 2000.
Hepatogastroenterology; 2002; 49(43):5-95. PubMed ID: 12356006
[No Abstract] [Full Text] [Related]
6. The 90-year anniversary of Katsusaburo Yamagiwa's carcinogenesis. Proceedings of the 1st International Awaji Liver Symposium. December 1, 2005. Awaji Island, Japan.
Oncology; 2007; 72 Suppl 1():1-140. PubMed ID: 18087176
[No Abstract] [Full Text] [Related]
7. Proceedings of a Bridge to a Consensus on Hepatocellular Carcinoma Management. The 2nd Asia Pacific Primary Liver Cancer Expert Meeting. July 1-3, 2011, Osaka, Japan.
Oncology; 2011; 81 Suppl 1():1-164. PubMed ID: 22371967
[No Abstract] [Full Text] [Related]
8. [Comprehensive strategy for extermination of hepatocellular carcinoma--prevention, diagnosis and treatment].
Kamiyama T; Hige S; Sakuhara Y; Chuma M; Shimamura T
Hokkaido Igaku Zasshi; 2011 May; 86(3):127-30. PubMed ID: 21688640
[TBL] [Abstract][Full Text] [Related]
9. The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.
Cabibbo G; Reig M; Gadaleta-Caldarola G; Galati G; Lombardi G; Mazza G; Marzi L; Saitta C; Nault JC; Sacco R
Future Oncol; 2016 Feb; 12(3):285-8. PubMed ID: 26776157
[TBL] [Abstract][Full Text] [Related]
10. The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.
Cabibbo G; Reig M; Gadaleta-Caldarola G; Galati G; Lombardi G; Mazza G; Marzi L; Saitta C; Nault JC; Sacco R
Future Oncol; 2016 Feb; 12(3):281-4. PubMed ID: 26775918
[TBL] [Abstract][Full Text] [Related]
11. Proceedings of the Fifth International Meeting, Hepatocellular Carcinoma: Eastern and Western Experiences Overview of the Conference.
Vauthey JN; Belghiti J; Makuuchi M
Ann Surg Oncol; 2008 Apr; 15(4):961. PubMed ID: 18236116
[No Abstract] [Full Text] [Related]
12. [Therapeutic advances in hepatocellular carcinoma].
Poupon R; Fartoux L; Rosmorduc O
Bull Acad Natl Med; 2008 Jan; 192(1):23-31; discussion 31-2. PubMed ID: 18663979
[TBL] [Abstract][Full Text] [Related]
13. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
Ichida T; Van Thiel DH; Hassanein T
Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
[TBL] [Abstract][Full Text] [Related]
14. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.
Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M;
Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027
[TBL] [Abstract][Full Text] [Related]
15. Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan.
Kudo M; Matsui O; Sakamoto M; Kitao A; Kim T; Ariizumi S; Ichikawa T; Kobayashi S; Imai Y; Izumi N; Fujinaga Y; Arii S
Oncology; 2013; 84 Suppl 1():21-7. PubMed ID: 23428854
[TBL] [Abstract][Full Text] [Related]
16. Basic science focus of third international symposium on liver cancer and hepatitis.
Skolnick AA
JAMA; 1996 Nov; 276(18):1457-8. PubMed ID: 8903244
[No Abstract] [Full Text] [Related]
17. Challenges of Clinical Research on Hepatocellular Carcinoma.
Kudo M; Kitano M; Sakurai T; Nishida N
Dig Dis; 2015 Oct; 33(6):780-90. PubMed ID: 26488399
[TBL] [Abstract][Full Text] [Related]
18. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
; ; ; ; ; ; ; ; ;
J Formos Med Assoc; 2018 May; 117(5):381-403. PubMed ID: 29074347
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis.
Arai K; Fukumoto T; Kido M; Tanaka M; Kuramitsu K; Kinoshita H; Komatsu S; Tsugawa D; Terai S; Matsumoto T; Goto T; Asari S; Toyama H; Ajiki T; Ku Y
Surg Today; 2017 Mar; 47(3):385-392. PubMed ID: 27465474
[TBL] [Abstract][Full Text] [Related]
20. Management of hepatocellular carcinoma in Japan.
Okita K
J Gastroenterol; 2006 Feb; 41(2):100-6. PubMed ID: 16568368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
